Global Gastrointestinal Drug Trends in 2022
Gastrointestinal Drug is part of OTC. You may also be interested in Contraceptive, Oral Hygiene and Dietary Supplement.
Global antacid medicine sales are projected to reach $205 million by 2026, down 0.2% from 2021's $213 million. Average annual growth since 2016 has been 2.5%. South Korea had the highest sales in 2021, at $65 million, followed by Italy, Germany, and Chile. Austria saw a 20.8% year-on-year increase, while New Zealand experienced a 6% decrease since 2016.
Top 10 countries
In 2022 major markets in the Gastrointestinal Drug Industry were:
Gastrointestinal Drug Market Data and Forecasts
How much the Gastrointestinal Drug industry is expected to grow to 2026?
More in Gastrointestinal Drug Industry for 2028Global Gastrointestinal Drug Industry Database
Improve your Knowledge with the latest Indicators and Trends
-
Expanding Horizons: Innovative Strategies in the Incretion Drugs Market Segment
Emerging trends in the incretion drugs market are being driven by an intensification of research and development (R&D), along with remarkable technological advancements. With a growing geriatric population suffering from diabetes and related complications, the demand for incretion drugs - prominent in regulating insulin and glucose levels in the body...
Discover more insights -
Inflammatory Bowel Disease Treatment: A Comprehensive Analysis of Market Dynamics & Forecasts
In the existing landscape of treatments for Inflammatory Bowel Disease (IBD), a range of therapeutics, from immunosuppressants to anti-inflammatory drugs, continues to dominate the market. However, as our understanding of the disease deepens, a shift towards personalized therapies and biologics has become increasingly conspicuous. Encouragingly, the advent of these novel...
Discover more insights -
Pharmaceutical Sector: Unraveling Opportunities in the Evolving IBS-C Drug Market Landscape
As a chronic condition affecting the digestive system, Irritable Bowel Syndrome with Constipation (IBS-C) has been steering notable transformations in the pharmaceutical sector. The enhanced emphasis on research and development, the amplified global healthcare spending, emerging therapy treatments, and increasing patient awareness about the disorder are part of the factors...
Discover more insights -
Gastrointestinal Therapeutics: Comprehensive Analysis of Global Trends and Market Dynamics
In recent years, an increase has been observed in the demand for gastrointestinal therapeutics owing to the growing prevalence of gastrointestinal disorders worldwide. Factors such as unhealthy dietary habits, increased stress levels, and the aging population contribute significantly to this trend. Additionally, the surging research & development activities in the...
Discover more insights -
Gastroparesis Drugs: Analyzing Industry Trends and Future Drug Developments
The gastroparesis pharmaceuticals market has been characterized by a steady growth driven by an escalating prevalence of diabetes and an aging global population, both prime causative factors of gastroparesis. Demand for prokinetic and antiemetic drugs, the primary classes of gastroparesis treatments, continues to surge. Despite this, unmet clinical needs remain...
Discover more insights